Her2 Expression in Prostatic Cancer:
- 1 October 2002
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- p. 1412-1414
- https://doi.org/10.1097/00005392-200210010-00026
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancerUrology, 2001
- Her-2-neu expression and progression toward androgen independence in human prostate cancer.JNCI Journal of the National Cancer Institute, 2000
- HER2 in prostate cancer--a viable target or innocent bystander?JNCI Journal of the National Cancer Institute, 2000
- Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cellsOncogene, 2000
- Prognostic value of immunohistochemical expression of the c-erbB-2 oncoprotein in metastasic prostate cancerInternational Journal of Cancer, 1999
- From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cellsProceedings of the National Academy of Sciences of the United States of America, 1999
- A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinaseNature Medicine, 1999
- RECOMBINANT ONCOTOXIN AR209 (ANTI-P185 erbB-2 ) DIMINISHES HUMAN PROSTATE CARCINOMA XENOGRAFTSJournal of Urology, 1999
- Prognostic significance of HER-2/neu gene amplification status by fluorescence in Situ hybridization of prostate carcinomaCancer, 1997
- c-erbB-2 oncoprotein: A potential biomarker of advanced prostate cancerThe Prostate, 1997